ADM and infectious disease: The findings of this study support and extend other observational studies evaluating the benefit of novel biomarkers (e.g. natriuretic peptides, adrenomedullin and vasopressin precursor peptides) in the diagnostic assessment and risk stratification of patients with cardiovascular and infectious disease [27].